- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0005033

About Vanta Clinical Research Limited
Data last updated:
Vanta Clinical Research Limited is a public limited company based in Secunderabad, Telangana, India, a subsidiary of Vanta Bioscience Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2018PLC126673. Its GSTIN is 36AAGCV5789C1ZY (Telangana).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dopesh Raja Mulakala and Shravan Chintapatla.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at No.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Vanta Bioscience. As per MCA filings, the company has open charges of ₹30.01 Cr and satisfied charges of ₹17 Cr on record.
Vanta Clinical Research Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0005033). For more details, the company can be reached via its website vantabio.com.
Company details
Recognitions & Rankings of Vanta Clinical Research
Contact details
Vanta Clinical Research Limited's registered office is in Secunderabad, Telangana. Its website is vantabio.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressNo.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Vanta Clinical Research Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vanta Clinical Research operates one associated brand: Vanta Bioscience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| GLP-certified preclinical contract research services are provided. | vantabio.com |
Financials of Vanta Clinical Research Limited
FY 2021 filings availableVanta Clinical Research Limited reported revenue of ₹1,983 (down 100% YoY) for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹1,983 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Vanta Clinical Research Limited, buy the company report.
Board of directors of Vanta Clinical Research Limited
Vanta Clinical Research has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dopesh Raja Mulakala | Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Shravan Chintapatla Also directs: Cebis India Limited, Dhruta Private Limited, Metatrade Network Private Limited and 1 more | Director | 18 Aug 2020 | 6 Years 2 Months | Current |
| Mulakala Sajan Kiran | Director | 07 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Vanta Clinical Research Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nano Formulations Private Limited | ₹6,800 (FY 2023) | -74.0% | Bhubaneswar, Odisha, India | |||
| Advanced Clinical Research Private Limited | ₹5,000 (FY 2025) | Bengaluru, Karnataka, India | ||||
| Vanta Clinical Research Limitedthis company | ₹1,983 (FY 2021) | -100.0% | Secunderabad, Telangana, India | |||
| Reametrix India Private Limited | ₹510 (FY 2019) | Bangalore, Karnataka, India |
To see the full peer comparison of Vanta Clinical Research Limited, buy the company report.
Auditor
Vanta Clinical Research Limited is audited by ITALIA & ASSOCIATES LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ITALIA & ASSOCIATES LLP | FY 2021 | 003793S |
Shareholding
The shareholding of Vanta Clinical Research Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vanta Clinical Research Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2022 | 100595387 | Others | ₹19.97 Cr | Open | |
| 01 Jul 2020 | 100353753 | State Bank of India | ₹10.04 Cr | Open | |
| 03 Dec 2019 | 100311512 | Axis Bank Limited | ₹17 Cr | Satisfied |
To see the full charge records of Vanta Clinical Research Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Vanta Clinical Research Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanta Clinical Research Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Vanta Clinical Research has 1 subsidiary company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Vayam Research Solutions Limited | U73100TG2018PLC127550 |
To see the full group structure of Vanta Clinical Research Limited, buy the company report.
GST
Vanta Clinical Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCV5789C1ZY | Telangana | Active | 20 Jun 2019 |
To see the full GST registrations and return filing status of Vanta Clinical Research Limited, buy the company report.
Recent activity
Vanta Clinical Research Limited has 7 board changes on record since 2018: 5 appointments and 2 cessations. The latest: Venkata Rao Sadhanala ceased to be Director on 20 Nov 2020.
3 earlier events are in the company report.
News
Frequently asked questions
Vanta Clinical Research is an active public limited company based in Secunderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 September 2018 (8+ years old) and is registered under CIN U73100TG2018PLC126673.
Vanta Clinical Research has 3 current directors:
- Dopesh Raja Mulakala - Director
- Shravan Chintapatla - Director
- Mulakala Sajan Kiran - Director
The latest financial statements of Vanta Clinical Research on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Vanta Clinical Research is 36AAGCV5789C1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Vanta Clinical Research is U73100TG2018PLC126673. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vanta Clinical Research was incorporated on 12 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vanta Clinical Research by revenue are Nano Formulations Private Limited, Advanced Clinical Research Private Limited, Reametrix India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Venkata Rao Sadhanala ceased to be Director on 20 Nov 2020. Shravan Chintapatla was appointed as Director on 18 Aug 2020. Mulakala Sajan Kiran was appointed as Director on 07 Mar 2020. Vanta Clinical Research has 7 board changes on record in total.
Yes, Vanta Clinical Research is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0005033).
Vanta Clinical Research can be reached through the website vantabio.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Vanta Clinical Research is at No.02G308G No.3FfSf1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.

